Beranda › Kanker (semua jenis) › Georgia › Atlanta
Uji klinis Kanker (semua jenis) di Atlanta, GA
49 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Atlanta (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Menerima pesertaFase 3
- Emory Winship Cancer Institute, Atlanta
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- Emory University Medical Center, Atlanta
Registry Study for Radiation Therapy Outcomes
Menerima pesertaStudi observasional
- Emory Proton Therapy Center, Atlanta
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Menerima pesertaFase 1
- Emory University, Atlanta
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Menerima pesertaFase 3
- Piedmont Physician Medical Oncology Atlanta, Atlanta
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Menerima pesertaFase 2
- Cancer Treatment Centers of America - Atlanta, Atlanta
- Emory University Winship Cancer Institute, Atlanta
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Menerima pesertaFase 2/3
- Winship Cancer Institute of Emory University, Atlanta
- Northside Hospital, Inc, Atlanta
Connect for Cancer Prevention Study (Connect)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Kaiser Permanente Georgia, Atlanta
Collection of Tissue Samples for Cancer Research
Menerima pesertaStudi observasional
- Emory University, Atlanta
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Menerima pesertaFase 2
- Winship Cancer Institute - Emory University, Atlanta
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Menerima pesertaFase 2
- Emory University, Atlanta
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Emory University School of Medicine- Grady Campus, Atlanta
- Winship Cancer Institute, Emory University, Atlanta
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Menerima pesertaStudi observasional
- Morehouse, Atlanta
- Piedmont Healthcare, Atlanta
- Winship Cancer Institute, Emory University, Atlanta
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Menerima pesertaFase 3
- Winship Cancer Institute of Emory University, Atlanta
Prostate Active Surveillance Study
Menerima pesertaStudi observasional
- Emory University, Atlanta
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Menerima pesertaFase 1
- Emory University Hospital, Atlanta
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Menerima pesertaFase 1
- Emory Winship Cancer Institute, Atlanta
Screening Strategies Among High-risk Populations for Anal Cancer
Menerima pesertaSukarelawan sehat diterima
- Grady Memorial Hospital, Atlanta
- The Ponce Center, Atlanta
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Menerima pesertaFase 3
- Urology of Greater Atlanta - Sandy Springs, Atlanta
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Menerima pesertaFase 1/2
- Winship Cancer Institute of Emory University, Atlanta
Safety of Anal Curcumin
Menerima pesertaFase 1Sukarelawan sehat diterima
- Grady Memorial Hospital, Atlanta
- Grady Hospital - Ponce De Leon Clinic, Atlanta
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Menerima pesertaFase 2
- Children's Healthcare of Atlanta, Inc. at Egleston, Atlanta
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- dan 3 lainnya
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Menerima pesertaFase 2
- Children's Healthcare of Atlanta, Atlanta
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Menerima pesertaFase 1/2
- Winship Cancer Institute - Emory University, Atlanta
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Menerima pesertaFase 1/2
- Winship Cancer Institute of Emory University /ID# 274830, Atlanta
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- Winship Cancer Center - Emory University, Atlanta
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Winship Cancer Institute, Emory University, Atlanta
A Multi Center Study of Sexual Toxicities After Radiotherapy
Menerima pesertaStudi observasional
- Emory University, Atlanta
Childhood Cancer Survivor Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Emory University/Children's Health Care of Atlanta, Atlanta
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Menerima peserta
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi jauhnya
Galleri® in the Medicare Population.
Menerima pesertaSukarelawan sehat diterima
- Morehouse School of Medicine Atlanta, Atlanta
- Morehouse School of Medicine Lee Street, Atlanta
- Morehouse School of Medicine Princeton Lakes, Atlanta
- dan 1 lainnya
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Menerima pesertaFase 1/2
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Menerima pesertaFase 1
- Winship Cancer Institute at Emory University, Atlanta
Video Inspired Discussions About Ethical Outcomes in Pediatrics
Menerima peserta
- Children's Hospital of Atlanta, Atlanta
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Menerima pesertaFase 2
- Winship Cancer Institute of Emory University, Atlanta
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Menerima pesertaFase 1/2
- Winship Cancer Institute, Emory University, Atlanta
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Menerima pesertaStudi observasional
- Morehouse, Atlanta
- Piedmont Healthcare, Atlanta
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Menerima pesertaFase 2
- Winship Cancer Institute of Emory University /ID# 230643, Atlanta
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- Morehouse School of Medicine (MSM), Atlanta
- Piedmont Healthcare, Atlanta
Caris Biorepository Research Protocol
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Emory University, Atlanta
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Menerima pesertaStudi observasional
- Emory University School of Medicine, Atlanta
Childhood Cancer Predisposition Study (CCPS)
Menerima pesertaStudi observasional
- Children's Healthcare of Atlanta (CHOA), Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
Menerima pesertaFase 1/2
- Emory - Winship Cancer Institute, Atlanta
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- Emory University Hospital Midtown, Atlanta
- Emory University, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
- dan 2 lainnya
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
Menerima pesertaFase 1
- Northside Hospital, Atlanta
Morehouse Total Cancer Care Protocol
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Morehouse School of Medicine, Atlanta
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY109 studi
- Boston, MA85 studi
- Los Angeles, CA74 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Washington, DC58 studi
- Durham, NC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Arlington, VA48 studi
- St. Louis, MO46 studi
Studi lain di Atlanta
- Kanker Paru Non-Sel Kecil47 studi
- Mieloma Multipel42 studi
- Kanker Payudara41 studi
- Kanker Prostat33 studi
- Leukemia Mieloid Akut31 studi
- Kanker Ovarium29 studi
- Kanker Kolorektal29 studi
- Kanker Paru29 studi
- Kanker Metastatik28 studi
- Gangguan Depresi Mayor25 studi
- Gagal Jantung25 studi
- Karsinoma Sel Skuamosa Kepala dan Leher24 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.